$356B
Pharma GTN bubble, 2024
Life Sciences · Specialty Pharma
Specialty pharmaceutical finance teams manage rebate liabilities, chargeback reconciliation, patient assistance program accounting, and REMS compliance documentation — simultaneously, every quarter. Archer configures NetSuite to bring that complexity under control, so the numbers your CFO presents are defensible the first time.
$356B
Pharma GTN bubble, 2024
99%
Of leaders say GTN complexity increased
70%
WAC reduction possible from pricing adjustments
61%
Cite PBM leverage as top GTN driver
53%
Report increased audit risk exposure
Chargebacks, rebates, co-pay assistance, specialty pharmacy fees, and government program obligations each require distinct accounting treatment, real-time estimation, and quarterly true-up. When these calculations live in siloed departmental spreadsheets — or worse, in an ERP that wasn't configured to handle them — the financial statements carry more uncertainty than leadership realizes.
Chargeback and rebate estimates built on prior-period assumptions frequently diverge from actual claims — creating true-up adjustments that move reported revenue significantly. Without automated accrual logic tied to contract terms and channel data, the estimates are always an approximation.
Pricing adjustments can reduce WAC by up to 70%; estimate errors compound across every payer tier
SP contracts, 3PL arrangements, and hub service agreements are often tracked in shared drives and email threads. When contract terms don't drive billing and accrual calculations in NetSuite, the financial impact of SP performance and fee structures is visible only at audit.
99% of specialty pharma finance leaders report that GTN management grew more complex in 2024
Co-pay cards, free drug programs, and foundation partnerships each carry distinct accounting treatment. Tracking program costs, utilization, and revenue impact without purpose-built workflows means the net revenue figure is always carrying some level of estimation risk.
53% of specialty pharma companies report lower audit-ready confidence on patient program accounting
HCP speaker fees, advisory board payments, and research grants must be aggregated, validated, and reported under Open Payments requirements. When those transactions aren't tracked at source in the ERP, the reporting process requires manual aggregation that introduces reconciliation risk.
Open Payments enforcement actions carry significant financial and reputational consequences
Archer's module set addresses the specific GTN, compliance, and contract management workflows where specialty pharma finance teams spend their time and accumulate their risk — deployed during implementation, not discovered during audit.
Archer Module
Automated accrual calculations for chargebacks, rebates, co-pay assistance, and specialty pharmacy fees — with contract-term-linked estimation logic and documented journal entry methodology that replaces departmental spreadsheets with a single, auditable source of truth.
Archer Module
Automated Open Payments reporting for HCP transactions — tracking speaker fees, advisory board payments, and research grants at source in NetSuite, aggregated to the reportable threshold, and exported in CMS-ready format without manual aggregation.
Archer Module
End-to-end management of SP agreements, 3PL contracts, hub service arrangements, and payer rebate agreements — with billing schedule automation, performance milestone tracking, and renewal workflows that drive financial calculations directly from contract terms.
Archer Module
Mobile expense capture for healthcare professional interactions — ensuring speaker program costs, meals, and HCP-related travel are captured at source with the HCP identifiers required for Sunshine Act aggregation, rather than reconstructed from card statements.
When GTN calculations are automated, Sunshine Act obligations are tracked at source, and SP contracts drive financial treatment in NetSuite, the specialty pharma finance function operates with the confidence that comes from knowing the numbers are right before they're presented.
Defensible
GTN at every close
Contract-linked accrual logic, automated true-up calculations, and documented estimation methodology mean your GTN position is supported by evidence — not revised after the audit finds a different assumption baked into the spreadsheet.
Automated
Open Payments reporting
HCP transaction tracking at source in NetSuite, aggregated to reportable thresholds, and exported in CMS-ready format — eliminating the quarterly manual aggregation that currently exposes the organization to reporting errors.
Faster
Close cycle on commercial revenue
When chargeback, rebate, and patient assistance calculations run automatically from contract terms and channel data, the close cycle for commercial revenue shrinks from a multi-week exercise into a verification process — freeing finance to spend time on analysis, not assembly.
Get started
Schedule a discovery call with Archer. We'll assess your current environment and show you what purpose-built NetSuite configuration looks like for specialty pharma at your commercial stage.